A Case of Migraine Aura-Like Visual Symptoms Responding to Lomerizine in a Patient With Neuronal Intranuclear Inclusion Disease

Ryo Tanaka; Takamasa Nukui; Mamoru Yamamoto; Shojiro Ichimata; Chisato Tamai; Jun Sone; Kyo Noguchi; Shunya Nakane; Yuji Nakatsuji

doi:10.1111/ncn3.12876

A Case of Migraine Aura-Like Visual Symptoms Responding to Lomerizine in a Patient With Neuronal Intranuclear Inclusion Disease

Ryo Tanaka, Takamasa Nukui, Mamoru Yamamoto, Shojiro Ichimata, Chisato Tamai, Jun Sone, Kyo Noguchi, Shunya Nakane^*, Yuji Nakatsuji

^*この論文の責任著者

研究成果: ジャーナルへの寄稿 › 学術論文 › 査読

抄録

A 62-year-old man experienced lower left blindness lasting 30 min to 1 h for 5 years. Treatment with lomerizine decreased its frequency. Subsequently, he was diagnosed with neuronal intranuclear inclusion disease by histological and genetic analysis. We consider two possibilities as follows: the visual symptoms are due to NIID and the visual symptoms and NIID are completely independent conditions that have coexisted by chance. The preventive effect of lomerizine on visual symptoms lasted for about 20 months from the start of treatment until his accidental death.

本文言語	英語
ジャーナル	Neurology and Clinical Neuroscience
DOI	https://doi.org/10.1111/ncn3.12876
出版ステータス	受理済み/印刷中 - 2025

ASJC Scopus 主題領域

神経学
臨床神経学

文献へのアクセス

10.1111/ncn3.12876

フィンガープリント

「A Case of Migraine Aura-Like Visual Symptoms Responding to Lomerizine in a Patient With Neuronal Intranuclear Inclusion Disease」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル

@article{19b78509ba944867adec8a4daeb01134,

title = "A Case of Migraine Aura-Like Visual Symptoms Responding to Lomerizine in a Patient With Neuronal Intranuclear Inclusion Disease",

abstract = "A 62-year-old man experienced lower left blindness lasting 30 min to 1 h for 5 years. Treatment with lomerizine decreased its frequency. Subsequently, he was diagnosed with neuronal intranuclear inclusion disease by histological and genetic analysis. We consider two possibilities as follows: the visual symptoms are due to NIID and the visual symptoms and NIID are completely independent conditions that have coexisted by chance. The preventive effect of lomerizine on visual symptoms lasted for about 20 months from the start of treatment until his accidental death.",

keywords = "aura, lomerizine, migraine, neuronal intranuclear inclusion disease (NIID)",

author = "Ryo Tanaka and Takamasa Nukui and Mamoru Yamamoto and Shojiro Ichimata and Chisato Tamai and Jun Sone and Kyo Noguchi and Shunya Nakane and Yuji Nakatsuji",

note = "Publisher Copyright: {\textcopyright} 2025 Japanese Society of Neurology and John Wiley & Sons Australia, Ltd.",

year = "2025",

doi = "10.1111/ncn3.12876",

language = "英語",

journal = "Neurology and Clinical Neuroscience",

issn = "2049-4173",

publisher = "John Wiley and Sons Inc.",

}

TY - JOUR

T1 - A Case of Migraine Aura-Like Visual Symptoms Responding to Lomerizine in a Patient With Neuronal Intranuclear Inclusion Disease

AU - Tanaka, Ryo

AU - Nukui, Takamasa

AU - Yamamoto, Mamoru

AU - Ichimata, Shojiro

AU - Tamai, Chisato

AU - Sone, Jun

AU - Noguchi, Kyo

AU - Nakane, Shunya

AU - Nakatsuji, Yuji

PY - 2025

Y1 - 2025

N2 - A 62-year-old man experienced lower left blindness lasting 30 min to 1 h for 5 years. Treatment with lomerizine decreased its frequency. Subsequently, he was diagnosed with neuronal intranuclear inclusion disease by histological and genetic analysis. We consider two possibilities as follows: the visual symptoms are due to NIID and the visual symptoms and NIID are completely independent conditions that have coexisted by chance. The preventive effect of lomerizine on visual symptoms lasted for about 20 months from the start of treatment until his accidental death.

AB - A 62-year-old man experienced lower left blindness lasting 30 min to 1 h for 5 years. Treatment with lomerizine decreased its frequency. Subsequently, he was diagnosed with neuronal intranuclear inclusion disease by histological and genetic analysis. We consider two possibilities as follows: the visual symptoms are due to NIID and the visual symptoms and NIID are completely independent conditions that have coexisted by chance. The preventive effect of lomerizine on visual symptoms lasted for about 20 months from the start of treatment until his accidental death.

KW - aura

KW - lomerizine

KW - migraine

KW - neuronal intranuclear inclusion disease (NIID)

UR - http://www.scopus.com/inward/record.url?scp=85215570157&partnerID=8YFLogxK

U2 - 10.1111/ncn3.12876

DO - 10.1111/ncn3.12876

M3 - 学術論文

AN - SCOPUS:85215570157

SN - 2049-4173

JO - Neurology and Clinical Neuroscience

JF - Neurology and Clinical Neuroscience

ER -